Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,385
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Placebo for ponsegromab (PF-06946860) solution for injection, Ponsegromab (PF-06946860)
Pfizer Ireland Pharmaceuticals Unlimited Company
Cancer cachexia
1 trial -
Ponsegromab (PF-06946860), Placebo for ponsegromab (pf-06946860) solution for injection
Pfizer Ireland Pharmaceuticals Unlimited Company
Heart failure
1 trial -
Ritlecitinib Tosilate, Placebo for pf-06651600-15
Pfizer Ireland Pharmaceuticals Unlimited Company
HIDRADENITIS SUPPURATIVA
1 trial -
Ritlecitinib tosilate, Placebo for pf-06651600-15, 100 mg, Placebo for pf-06651600-15, 50 mg, LORATADINE, Ritlecitinib Tosilate
Pfizer Ireland Pharmaceuticals Unlimited Company
CHRONIC SPONTANEOUS URTICARIA
1 trial -
Saxenda 6 mg/mL solution for injection in pre-filled pen, Saxenda 6 mg/mL solution for injection in pre-filled pen, Placebo for PF-07976016, Saxenda 6 mg/mL solution for injection in pre-filled pen
Pfizer Ireland Pharmaceuticals Unlimited Company
Obesity, Overweight
1 trial -
Sigvotatug vedotin, PF-08634404
Pfizer Ireland Pharmaceuticals Unlimited Company
Advanced Solid Tumors
1 trial -
The placebo for the pantoprazole sodium 40 mg, 20 mg, 10 mg and 5 mg delayed release granules in HPMC capsules, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE
Pfizer Ireland Pharmaceuticals Unlimited Company
EROSIVE ESOPHAGITIS
1 trial -
A Phase 1 study to evaluate the metabolism of [14C]PF-07104091 in healthy adult male participants
Pfizer Ireland Pharmaceuticals Unlimited Company
(HR) -positive human epidermal growth factor receptor 2 (HER2) -negative breast cancer (BC), non-small cell lung cancer (NSCLC), ovarian cancer, and triple negative breast cancer (TNBC)
1 trial -
A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-06821497
Pfizer Ireland Pharmaceuticals Unlimited Company
small cell lung cancer (SCLC), castration resistant prostate cancer (CRPC), follicular lymphoma (FL)
1 trial -
A Study of PF-08046031 in Adults With Advanced Melanoma and Other Solid Tumors
Pfizer Ireland Pharmaceuticals Unlimited Company
Melanoma (or) malignant melanoma Non-small cell lung cancer Head and neck squamous cell carcinoma Esophageal cancer
1 trial -
A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults
Pfizer Ireland Pharmaceuticals Unlimited Company
Migraine with or without aura
1 trial -
A Study to Establish the Bioequivalence of Free Acid Tafamidis 61 mg Capsule and Tablet, and Evaluate the Safety and Tolerability of the 61 mg Tablet in Healthy Adults Under Fed Conditions
Pfizer Ireland Pharmaceuticals Unlimited Company
Transthyretin amyloidosis
1 trial -
A Study to Learn About How Different Formulations of the Medicine Called Mevrometostat are Taken up Into the Blood in Healthy Adult Participants
Pfizer Ireland Pharmaceuticals Unlimited Company
Small cell lung cancer, Castration-resistant prostate cancer, Follicular lymphoma
1 trial -
A Study to Learn About if the Study Medicine Called Ibuzatrelvir changes how the body process the other Medicine Dabigatran Etexilate in healthy adults
Pfizer Ireland Pharmaceuticals Unlimited Company
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
1 trial -
A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin
Pfizer Ireland Pharmaceuticals Unlimited Company
Inflammatory bowel disease
1 trial -
A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition
Pfizer Ireland Pharmaceuticals Unlimited Company
Older adults at risk of malnutrition
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07293893 are Tolerated and Act in the Body of Healthy Adults.
Pfizer Ireland Pharmaceuticals Unlimited Company
heart failure with preserved ejection fraction
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 are Tolerated and Act in the Body in Healthy Adults
Pfizer Ireland Pharmaceuticals Unlimited Company
Heart failure
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 are Tolerated and Act in the Body in Healthy Adults
Pfizer Ireland Pharmaceuticals Unlimited Company
Clonal hematopoiesis
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 are Tolerated and Act in the Body in Healthy Adults.
Pfizer Ireland Pharmaceuticals Unlimited Company
clonal hematopoiesis
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 are Tolerated and Act in the Body in Healthy Adults
Pfizer Ireland Pharmaceuticals Unlimited Company
IgA nephropathy
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 are Tolerated and Act in the Body in Healthy Adults
Pfizer Ireland Pharmaceuticals Unlimited Company
CCI
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 are Tolerated and Act in the Body of Healthy Adults
Pfizer Ireland Pharmaceuticals Unlimited Company
Rheumatoid arthritis and Systemic Lupus Erythematosus
1 trial -
A Study to Learn How Different Forms of The Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults
Pfizer Ireland Pharmaceuticals Unlimited Company
Primary and secondary hypertension, and heart failure
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources